Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Proliferative Kidney Disease and Proliferative Darkening Syndrome are Linked with Brown Trout (Salmo trutta fario) Mortalities in the Pre-Alpine Isar River.

Arndt D, Fux R, Blutke A, Schwaiger J, El-Matbouli M, Sutter G, Langenmayer MC.

Pathogens. 2019 Oct 6;8(4). pii: E177. doi: 10.3390/pathogens8040177.

2.

Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin.

Willmann S, Frei M, Sutter G, Coboeken K, Wendl T, Eissing T, Lippert J, Stass H.

CPT Pharmacometrics Syst Pharmacol. 2019 Sep;8(9):654-663. doi: 10.1002/psp4.12446. Epub 2019 Aug 7.

3.

Piscine Orthoreovirus 3 Is Not the Causative Pathogen of Proliferative Darkening Syndrome (PDS) of Brown Trout (Salmo trutta fario).

Fux R, Arndt D, Langenmayer MC, Schwaiger J, Ferling H, Fischer N, Indenbirken D, Grundhoff A, Dölken L, Adamek M, Steinhagen D, Sutter G.

Viruses. 2019 Jan 28;11(2). pii: E112. doi: 10.3390/v11020112.

4.

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.

Veit S, Jany S, Fux R, Sutter G, Volz A.

Viruses. 2018 Dec 16;10(12). pii: E718. doi: 10.3390/v10120718.

5.

Cross-sectional study on viraemia and shedding of porcine circovirus type 2 in a subclinically infected multiplier sow herd.

Eddicks M, Beuter B, Stuhldreier R, Nolte T, Reese S, Sutter G, Ritzmann M, Fux R.

Vet Rec. 2019 Feb 9;184(6):189. doi: 10.1136/vr.105069. Epub 2018 Nov 9.

PMID:
30413676
6.

Generation of therapeutic antisera for emerging viral infections.

Schmidt R, Beltzig LC, Sawatsky B, Dolnik O, Dietzel E, Krähling V, Volz A, Sutter G, Becker S, von Messling V.

NPJ Vaccines. 2018 Oct 5;3:42. doi: 10.1038/s41541-018-0082-4. eCollection 2018.

7.

Immunogenic cell death of dendritic cells following modified vaccinia virus Ankara infection enhances CD8+ T cell proliferation.

Tappe KA, Budida R, Stankov MV, Frenz T, R Shah H, Volz A, Sutter G, Kalinke U, Behrens GMN.

Eur J Immunol. 2018 Dec;48(12):2042-2054. doi: 10.1002/eji.201847632. Epub 2018 Oct 10.

PMID:
30259962
8.

Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections.

Langenmayer MC, Lülf-Averhoff AT, Adam-Neumair S, Sutter G, Volz A.

Viruses. 2018 Aug 24;10(9). pii: E452. doi: 10.3390/v10090452.

9.

N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle.

Wernike K, Mundt A, Link EK, Aebischer A, Schlotthauer F, Sutter G, Fux R, Beer M.

Vaccine. 2018 Aug 16;36(34):5116-5123. doi: 10.1016/j.vaccine.2018.07.047. Epub 2018 Jul 23.

PMID:
30049630
10.

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.

de Vries RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, van Trierum SE, Pronk MR, Lamers MM, Richard M, Nieuwenhuijse DF, Koopmans MPG, Kreijtz JHCM, Fouchier RAM, Osterhaus ADME, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2018 Jul 13;218(4):614-623. doi: 10.1093/infdis/jiy214.

11.

Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S.

Langenmayer MC, Lülf-Averhoff AT, Adam-Neumair S, Fux R, Sutter G, Volz A.

Biologicals. 2018 Jul;54:58-62. doi: 10.1016/j.biologicals.2018.05.004.

PMID:
29759890
12.

Manifold Roles of CCR7 and Its Ligands in the Induction and Maintenance of Bronchus-Associated Lymphoid Tissue.

Fleige H, Bosnjak B, Permanyer M, Ristenpart J, Bubke A, Willenzon S, Sutter G, Luther SA, Förster R.

Cell Rep. 2018 Apr 17;23(3):783-795. doi: 10.1016/j.celrep.2018.03.072.

13.

Application of light sheet microscopy for qualitative and quantitative analysis of bronchus-associated lymphoid tissue in mice.

Mzinza DT, Fleige H, Laarmann K, Willenzon S, Ristenpart J, Spanier J, Sutter G, Kalinke U, Valentin-Weigand P, Förster R.

Cell Mol Immunol. 2018 Oct;15(10):875-887. doi: 10.1038/cmi.2017.150. Epub 2018 Feb 12.

14.

Full genome characterization of porcine circovirus type 3 isolates reveals the existence of two distinct groups of virus strains.

Fux R, Söckler C, Link EK, Renken C, Krejci R, Sutter G, Ritzmann M, Eddicks M.

Virol J. 2018 Jan 29;15(1):25. doi: 10.1186/s12985-018-0929-3.

15.

E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.

Volz A, Jany S, Freudenstein A, Lantermann M, Ludwig H, Sutter G.

Viruses. 2018 Jan 4;10(1). pii: E21. doi: 10.3390/v10010021.

16.

Type I interferon receptor signaling delays Kupffer cell replenishment during acute fulminant viral hepatitis.

Borst K, Frenz T, Spanier J, Tegtmeyer PK, Chhatbar C, Skerra J, Ghita L, Namineni S, Lienenklaus S, Köster M, Heikenwaelder M, Sutter G, Kalinke U.

J Hepatol. 2018 Apr;68(4):682-690. doi: 10.1016/j.jhep.2017.11.029. Epub 2017 Dec 21.

PMID:
29274730
17.

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.

Altenburg AF, van de Sandt CE, Li BWS, MacLoughlin RJ, Fouchier RAM, van Amerongen G, Volz A, Hendriks RW, de Swart RL, Sutter G, Rimmelzwaan GF, de Vries RD.

Sci Rep. 2017 Aug 17;7(1):8580. doi: 10.1038/s41598-017-08719-y.

18.

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.

Link EK, Brandmüller C, Suezer Y, Ameres S, Volz A, Moosmann A, Sutter G, Lehmann MH.

Vaccine. 2017 Sep 12;35(38):5131-5139. doi: 10.1016/j.vaccine.2017.08.019. Epub 2017 Aug 14.

PMID:
28818566
19.

Sus scrofa papillomavirus 2 - genetic characterization of a novel suid papillomavirus from wild boar in Germany.

Link EK, Hoferer M, Strobel B, Rigbers K, Langenmayer MC, Sutter G, Fux R.

J Gen Virol. 2017 Aug;98(8):2113-2117. doi: 10.1099/jgv.0.000868. Epub 2017 Jul 31.

PMID:
28758619
20.

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.

Tan WG, Zubkova I, Kachko A, Wells F, Adler H, Sutter G, Major ME.

PLoS One. 2017 Jul 21;12(7):e0181578. doi: 10.1371/journal.pone.0181578. eCollection 2017.

21.

Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells.

Frey TR, Lehmann MH, Ryan CM, Pizzorno MC, Sutter G, Hersperger AR.

Virology. 2017 Sep;509:98-111. doi: 10.1016/j.virol.2017.06.010.

22.

Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.

Rappuoli R, Sutter G.

Curr Opin Virol. 2017 Apr;23:vi-viii. doi: 10.1016/j.coviro.2017.06.001. No abstract available.

PMID:
28622999
23.

[Occurrence of genotypes of porcine circovirus (PCV2) in pig farms using different vaccination strategies against PCV2].

Eddicks M, Szikora F, Walhöfer N, Sauter Louis C, Reese S, Banholzer E, Reiner G, Sutter G, Ritzmann M, Fux R.

Tierarztl Prax Ausg G Grosstiere Nutztiere. 2017 Apr 19;45(2):90-97. doi: 10.15653/TPG-160547. Epub 2017 Mar 22. German.

PMID:
28327779
24.

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Volz A, Sutter G.

Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1. Review.

PMID:
28057259
25.

Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Altenburg AF, van de Sandt CE, van Trierum SE, De Gruyter HLM, van Run PRWA, Fouchier RAM, Roose K, Saelens X, Volz A, Sutter G, de Vries RD, Rimmelzwaan GF.

J Virol. 2016 Oct 28;90(22):10209-10219. doi: 10.1128/JVI.01633-16. Print 2016 Nov 15.

26.

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes.

Lülf AT, Freudenstein A, Marr L, Sutter G, Volz A.

Virology. 2016 Dec;499:322-330. doi: 10.1016/j.virol.2016.09.006. Epub 2016 Oct 11.

27.

Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis.

Ohmer M, Weber A, Sutter G, Ehrhardt K, Zimmermann A, Häcker G.

Cell Death Dis. 2016 Aug 18;7(8):e2340. doi: 10.1038/cddis.2016.242.

28.

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

Rollier CS, Verschoor EJ, Verstrepen BE, Drexhage JA, Paranhos-Baccala G, Liljeström P, Sutter G, Arribillaga L, Lasarte JJ, Bartosch B, Cosset FL, Inchauspe G, Heeney JL.

Gene Ther. 2016 Oct;23(10):753-759. doi: 10.1038/gt.2016.55. Epub 2016 Jul 14.

PMID:
27416077
29.

Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.

Ducatez MF, Becker J, Freudenstein A, Delverdier M, Delpont M, Sutter G, Guérin JL, Volz A.

Vet Microbiol. 2016 Jun 30;189:59-67. doi: 10.1016/j.vetmic.2016.04.025. Epub 2016 Apr 26.

PMID:
27259828
30.

Low prevalence of porcine circovirus type 2 infections in farrowing sows and corresponding pre-suckling piglets in southern German pig farms.

Eddicks M, Koeppen M, Willi S, Fux R, Reese S, Sutter G, Stadler J, Ritzmann M.

Vet Microbiol. 2016 May 1;187:70-74. doi: 10.1016/j.vetmic.2016.03.010. Epub 2016 Mar 16.

PMID:
27066711
31.

CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection.

Lehmann MH, Torres-Domínguez LE, Price PJ, Brandmüller C, Kirschning CJ, Sutter G.

J Leukoc Biol. 2016 Jun;99(6):1057-64. doi: 10.1189/jlb.4MA0815-376RR. Epub 2016 Mar 18. Review.

PMID:
26992431
32.

Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.

Volz A, Lim S, Kaserer M, Lülf A, Marr L, Jany S, Deeg CA, Pijlman GP, Koraka P, Osterhaus AD, Martina BE, Sutter G.

Vaccine. 2016 Apr 7;34(16):1915-26. doi: 10.1016/j.vaccine.2016.02.042. Epub 2016 Mar 2.

PMID:
26939903
33.

In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.

Halle S, Keyser KA, Stahl FR, Busche A, Marquardt A, Zheng X, Galla M, Heissmeyer V, Heller K, Boelter J, Wagner K, Bischoff Y, Martens R, Braun A, Werth K, Uvarovskii A, Kempf H, Meyer-Hermann M, Arens R, Kremer M, Sutter G, Messerle M, Förster R.

Immunity. 2016 Feb 16;44(2):233-45. doi: 10.1016/j.immuni.2016.01.010. Epub 2016 Feb 9.

34.

Myristoylation increases the CD8+T-cell response to a GFP prototype antigen delivered by modified vaccinia virus Ankara.

Marr L, Lülf AT, Freudenstein A, Sutter G, Volz A.

J Gen Virol. 2016 Apr;97(4):934-40. doi: 10.1099/jgv.0.000425. Epub 2016 Feb 10.

PMID:
26864442
35.

[Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine].

Volz A, Fux R, Langenmayer MC, Sutter G.

Berl Munch Tierarztl Wochenschr. 2015 Nov-Dec;128(11-12):464-72. Review. German.

PMID:
26697713
36.

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.

Haagmans BL, van den Brand JM, Raj VS, Volz A, Wohlsein P, Smits SL, Schipper D, Bestebroer TM, Okba N, Fux R, Bensaid A, Solanes Foz D, Kuiken T, Baumgärtner W, Segalés J, Sutter G, Osterhaus AD.

Science. 2016 Jan 1;351(6268):77-81. doi: 10.1126/science.aad1283. Epub 2015 Dec 17.

37.

Rusa alfredi papillomavirus 1 - a novel deltapapillomavirus inducing endemic papillomatosis in the endangered Visayan spotted deer.

Fux R, Langenmayer MC, Jörgens D, Schubert C, Heckel JO, Sutter G.

J Gen Virol. 2016 Jan;97(1):128-33. doi: 10.1099/jgv.0.000340. Epub 2015 Nov 10.

PMID:
26555294
38.

Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations.

Kunze C, Mentzel HJ, Krishnamurthy R, Fleck R, Stenzel M, Bhargava R, Burrowes D, Sutter G, Schultze-Mosgau M, Santiuste M, Hahn G.

Invest Radiol. 2016 Jan;51(1):50-7. doi: 10.1097/RLI.0000000000000204.

PMID:
26340504
39.

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.

Volz A, Kupke A, Song F, Jany S, Fux R, Shams-Eldin H, Schmidt J, Becker C, Eickmann M, Becker S, Sutter G.

J Virol. 2015 Aug;89(16):8651-6. doi: 10.1128/JVI.00614-15. Epub 2015 May 27.

40.

Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine.

de Vries RD, De Gruyter HL, Bestebroer TM, Pronk M, Fouchier RA, Osterhaus AD, Sutter G, Kreijtz JH, Rimmelzwaan GF.

Emerg Infect Dis. 2015 Jun;21(6):1086-8. doi: 10.3201/eid2106.150021. No abstract available.

41.

Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky.

Danon YL, Sutter G.

Clin Vaccine Immunol. 2015 May;22(5):604. doi: 10.1128/CVI.00782-14. No abstract available.

42.

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage.

Lehmann MH, Price PJ, Brandmüller C, Sutter G.

Virol J. 2015 Feb 12;12:21. doi: 10.1186/s12985-015-0252-1.

43.

Detection of a new cluster of porcine circovirus type 2b strains in domestic pigs in Germany.

Eddicks M, Fux R, Szikora F, Eddicks L, Majzoub-Altweck M, Hermanns W, Sutter G, Palzer A, Banholzer E, Ritzmann M.

Vet Microbiol. 2015 Apr 17;176(3-4):337-43. doi: 10.1016/j.vetmic.2015.01.013. Epub 2015 Jan 24.

PMID:
25669598
44.

Complement component C5 recruits neutrophils in the absence of C3 during respiratory infection with modified vaccinia virus Ankara.

Price PJ, Bánki Z, Scheideler A, Stoiber H, Verschoor A, Sutter G, Lehmann MH.

J Immunol. 2015 Feb 1;194(3):1164-8. doi: 10.4049/jimmunol.1301410. Epub 2014 Dec 29.

45.

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

Kreijtz JH, Goeijenbier M, Moesker FM, van den Dries L, Goeijenbier S, De Gruyter HL, Lehmann MH, Mutsert Gd, van de Vijver DA, Volz A, Fouchier RA, van Gorp EC, Rimmelzwaan GF, Sutter G, Osterhaus AD.

Lancet Infect Dis. 2014 Dec;14(12):1196-207. doi: 10.1016/S1473-3099(14)70963-6. Epub 2014 Oct 30.

PMID:
25455987
46.

A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.

Kreijtz JH, Wiersma LC, De Gruyter HL, Vogelzang-van Trierum SE, van Amerongen G, Stittelaar KJ, Fouchier RA, Osterhaus AD, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2015 Mar 1;211(5):791-800. doi: 10.1093/infdis/jiu528. Epub 2014 Sep 22.

47.

Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.

van den Doel P, Volz A, Roose JM, Sewbalaksing VD, Pijlman GP, van Middelkoop I, Duiverman V, van de Wetering E, Sutter G, Osterhaus AD, Martina BE.

PLoS Negl Trop Dis. 2014 Sep 4;8(9):e3101. doi: 10.1371/journal.pntd.0003101. eCollection 2014 Sep.

48.

Establishing quality control ranges for temocillin following CLSI-M23-A3 guideline.

Maurissen W, Sutter GD, De Beenhouwer H, Frans J, Van den Abeele AM, Cartuyvels R, Laffut W, Vandecandelaere P, Coppens G.

Acta Clin Belg. 2015 Feb;70(1):11-5. doi: 10.1179/2295333714Y.0000000066. Epub 2014 Aug 31.

PMID:
25176405
49.

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.

Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A.

Viruses. 2014 Jul 17;6(7):2735-61. doi: 10.3390/v6072735. Review.

50.

Supplemental Content

Loading ...
Support Center